Answers are grounded in this paper and cite their sources.
Analysis reveals stable claim rates and predominant diagnostic delays in pancreatic cancer cases, suggesting areas for improvement.
The claim rate of 1.5% was stable, with about one in five claims approved. Diagnostic delay was the predominant cause, with several stakeholders involved across the healthcare system.
No takes yet. Share an insight, caveat, or question.
Søreide et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: